BRIEF-U.S. FDA approves Zinbryta to treat multiple sclerosis

* Zinbryta has a boxed warning & is available only through a restricted distribution program under a risk evaluation and mitigation strategy
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.